中国寄生虫学与寄生虫病杂志 ›› 2012, Vol. 30 ›› Issue (5): 3-349-353.

• 论著 • 上一篇    下一篇

他克莫司滴鼻治疗过敏性哮喘小鼠的实验研究

喻海琼1,2,袁萍2,黄映华1,李惠琼1,周一平1 *   

  1. 1 深圳福田区人民医院,深圳518033;2 深圳大学医学院过敏反应与免疫学研究所,深圳518060
  • 出版日期:2012-10-30 发布日期:2013-02-05

Study of Tacrolimus Intranasal Treatment for Allergic Asthma in Mice

YU Hai-qiong1,2,YUAN Ping2,HUANG Ying-hua1,LI Hui-qiong1,ZHOU Yi-ping1 *   

  1. 1 Futian People′s Hospital,Shenzhen 518033,China;2 Allergy and Immunology Institute,Shenzhen University,Shenzhen 518060,China
  • Online:2012-10-30 Published:2013-02-05

摘要: 【摘要】  目的  探讨免疫抑制剂他克莫司(tacrolimus)滴鼻疗法对过敏性哮喘小鼠的治疗效果和机制。  方法  将24只雌性BALB/c小鼠随机分为4组,分别为阴性对照组(A组)、模型对照组(B组)、低剂量治疗组(C组)和高剂量治疗组(D组)。除A组外,其他各组在第0、7和14天分别用50 μg粉尘螨变应原提取液+2 mg氢氧化铝腹腔注射小鼠致敏,A组腹腔注射等量生理盐水。自第28天开始,乙醚麻醉小鼠后,A、B、C和D组分别用100 μl生理盐水、PBS、0.01%他克莫司和0.1%他克莫司滴鼻治疗,连续治疗7 d,1次/d,每次治疗同时用50 μl(1 mg/ml)粉尘螨变应原滴鼻激发1次。末次激发后24 h,检测小鼠的气道高反应性;末次激发后48 h,处死小鼠,行支气管肺泡灌洗,无菌摘取肺组织和脾脏。记录支气管肺泡灌洗液(BALF)中细胞总数和嗜酸粒细胞数。ELISA法检测BALF和脾细胞培养上清的白介素4(IL?鄄4)、IL?鄄5和γ干扰素(IFN?鄄γ)水平。通过苏木素?鄄伊红染色(HE)和阿尔辛蓝(AB)染色观察小鼠肺部炎症和杯状细胞黏液分泌情况。  结果  与B组相比,D组气道高反应性显著降低(P<0.05),肺部病理改变(炎症细胞浸润和黏液分泌)明显减轻。D组的BALF中细胞总数[(29.9±5.2)×104/ml](P<0.05)和嗜酸粒细胞数[(4.3±0.8)×104/ml](P<0.01)均比B组[分别为(59.3±6.0)×104/ml和(22.7±5.7)×104/ml]显著减少。D组BALF中IL?鄄4 [(22.49±4.96) pg/ml] (P<0.05)、IL?鄄5[(43.90±13.15) pg/ml](P<0.01)和IFN?鄄γ [(10.17±1.09) pg/ml](P<0.05)均显著低于B组[分别为(57.02±7.38)、(133.49±15.63)和(15.32±3.23) pg/ml]。D组的脾细胞培养上清中IL?鄄4 [(22.54±4.58) pg/ml]、IL?鄄5 [(36.31±20.85) pg/ml]和IFN?鄄γ[(11.28±1.79) pg/ml]亦显著低于B组[分别为(56.34±6.21)、(72.32±6.23)和(18.82±1.88) pg/ml](均P<0.05)。整个实验中,C组与B组均无明显差异。  结论  他克莫司对粉尘螨致敏小鼠具有一定免疫治疗作用,可能与其抑制T淋巴细胞因子分泌有关。

关键词: 他克莫司, 小鼠, 滴鼻治疗, 哮喘模型, 粉尘螨

Abstract: 【Abstract】   Objective   To explore the efficacy of intranasal treatment by immunosuppressant tacrolimus for allergic asthma and its mechanism in mice.  Methods  24 female BALB/c mice were randomly divided into 4 groups: group A (negative control), group B (model control), group C (low dose treatment), and group D (high dose treatment). Mice in group A were treated with saline (100 μl). Other groups were sensitized intraperitoneally with allergen extracts of Dermatophagoides farinae (Der f) absorbed to Al(OH)3 at day 0, 7, and 14. From day 28, groups A, B, C, and D were intranasally treated with saline, PBS, 0.01% tacrolimus, and 0.1% tacrolimus, respectively, once per day for 7 d, and followed by intranasal challenge with 50 μl Der f extracts in the mean time. 24 h after the last challenge, the airway hyper-responsiveness (AHR) were detected. At 48 h after the last challenge, the mice were sacrificed, the bronchoalveolar lavage fluid (BALF) was collected, the lungs and spleen were aseptically removed. The total cell number and cell classification of BALF were recorded. The level of interleukin-4 (IL-4), interleukin-5 (IL-5), interferon-γ (IFN-γ) in BALF and in spleen cells culture supernatants was detected by ELISA. The lung inflammation and mucus secretion were observed in mice by HE (haematoxylin and eosin) staining and AB (Alcian Blue) staining.  Results  Compared with group B, AHR (P<0.05) and airway inflammation in group D significantly reduced. The number of total cells [(29.92±5.20)×104/ml] (P<0.05) and eosinophils [(4.33±0.75)×104/ml] (P<0.01) in group D greatly decreased than those of group B [(59.33±5.99)×104/ml and (22.67±5.65)×104/ml]. The level of IL-4 [(22.49±4.96) pg/ml] (P<0.05), IL-5 [(43.90±13.15) pg/ml] (P<0.01) and IFN-γ [(10.17±1.09) pg/ml] (P<0.05) in BALF significantly decreased (P<0.05) than those of group B [(57.02±7.38), (133.49±15.63) and (15.32±3.23) pg/ml, respectively]. The level of IL-4 [(22.54±4.58) pg/ml], IL-5 [(36.31±20.85) pg/ml] and IFN-γ [(11.28±1.79) pg/ml] in spleen cell culture supernatant all sig-nificantly decreased (P<0.05) than those of group B [(56.34±6.21), (72.32±6.23) and (18.82±1.88) pg/ml, respectively]. There was no significant difference between group C and group B.  Conclusion  Tacrolimus shows certain immune therapeu-tic effect on dust mite sensitized mice, and this effect may be attributed to its inhibition on T lymphocyte factor secretion.

Key words: Tacrolimus, Mice, Intranasal treatment, Asthma model, Dermatophagoides farinae